Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Low-density-lipoprotein (LDL) Cholesterol”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Looking for participantsNCT06903546
What this trial is testing

The Effect of Propolis Administration on Cholesterol Level in Diabetic Type 2 Patients

Who this might be right for
Diabetes Mellitus Type 2
Universitas Indonesia 64
Not applicableStudy completedNCT03118583
What this trial is testing

Effects of a Dietary Supplement on Lipoprotein Lipids and Inflammatory Markers

Who this might be right for
Healthy Volunteers
Midwest Center for Metabolic and Cardiovascular Research 12
Not applicableUnknownNCT03152656
What this trial is testing

A Registration Study for Familial Hypercholesterolemia in Taiwan

Who this might be right for
Familial Hypercholesterolemia
National Taiwan University Hospital 1,000
Not applicableStudy completedNCT02770313
What this trial is testing

Weekly ONe-Day WatER-only Fasting InterventionaL Trial for Low-Density Lipoprotein Cholesterol Reduction

Who this might be right for
Intermittent Fasting
Intermountain Health Care, Inc. 103
Post-approval studies (Phase 4)Active Not RecruitingNCT06941792
What this trial is testing

Inclisiran Effectiveness in China: a Pragmatic Randomized Trial

Who this might be right for
Coronary Heart Disease
Novartis Pharmaceuticals 1,590
Post-approval studies (Phase 4)Study completedNCT02938949
What this trial is testing

Alirocumab in Patients With Acute Myocardial Infarction

Who this might be right for
Myocardial InfarctionHypercholesterolemia
Virginia Commonwealth University 20
Early research (Phase 1)Looking for participantsNCT07626281
What this trial is testing

Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of a New Formulation of Inclisiran Containing Polysorbate 80 Compared to the Currently Marketed Formulation

Who this might be right for
Inclisiran Formulation
Novartis Pharmaceuticals 120
Large-scale testing (Phase 3)Study completedNCT00080275
What this trial is testing

Evaluation of the Safety & Efficacy of a Combination of Niacin ER & Simvastatin in Patients With Dyslipidemia (OCEANS)

Who this might be right for
Hypercholesterolemia
Kos Pharmaceuticals 600
Early research (Phase 1)Study completedNCT07423598
What this trial is testing

Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics With AZD0780 Following Repeated Dose Administration in Healthy Adults With Elevated LDL-C Levels

Who this might be right for
Healthy Participants
AstraZeneca 40
Testing effectiveness (Phase 2)Study completedNCT02541201
What this trial is testing

The Effect of a Plant Sterols-Enriched Low-Fat Milk on Lipid Profile in Healthy Southern Chinese (COME-PASS)

Who this might be right for
Dyslipidemia
The University of Hong Kong 221
Post-approval studies (Phase 4)Study completedNCT06925100
What this trial is testing

Investigate the Effectiveness and Safety of Bempedoic Acid in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia in Taiwan

Who this might be right for
Primary Hypercholesterolemia or Mixed Hyperlipidemia
Daiichi Sankyo 180
Large-scale testing (Phase 3)Study completedNCT00654446
What this trial is testing

IIIb 6 Week Open Label Multicentre Rosuvastatin & Simvastatin

Who this might be right for
Fredrickson Type IIa & Type IIb Dyslipidaemia
AstraZeneca 442
Early research (Phase 1)Study completedNCT01487460
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAP311 in Healthy Subjects and Dyslipidemic Patients

Who this might be right for
DyslipidemiaHealthy Volunteers
Novartis Pharmaceuticals 137
Not applicableLooking for participantsNCT06649240
What this trial is testing

Optimal Target Low-density Lipoprotein Cholesterol Level for Small Vessel Occlusion Stroke

Who this might be right for
Ischemic StrokeSmall Vessel Cerebrovascular DiseaseCholesterol, LDL+2 more
Seoul National University Hospital 4,016
Not applicableStudy completedNCT01020578
What this trial is testing

Low Density Lipoprotein (LDL) Cholesterol Metabolism in Impaired Glucose Tolerance

Who this might be right for
Impaired Glucose Tolerance
University of Sao Paulo General Hospital 29
Large-scale testing (Phase 3)Not Yet RecruitingNCT07441317
What this trial is testing

QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated Low Density Lipoprotein Cholesterol (LDL-C)

Who this might be right for
Primary Hypercholesterolemia or Mixed Hyperlipidemia
Qilu Pharmaceutical Co., Ltd. 780
Large-scale testing (Phase 3)Study completedNCT05888103
What this trial is testing

Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.

Who this might be right for
Primary Hypercholesterolemia or Mixed Dyslipidemia
Novartis Pharmaceuticals 207
Not applicableStudy completedNCT00535886
What this trial is testing

The Effects of Natural Versus Man-Made Trans Fatty Acids on Lipoprotein Profiles: A Pilot Study

Who this might be right for
Cardiovascular DiseaseDiabetesDyslipidemia
UCSF Benioff Children's Hospital Oakland 15
Early research (Phase 1)Looking for participantsNCT07428473
What this trial is testing

STX-1150 in Participants With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)

Who this might be right for
Elevated LDL-C and High Cholesterol
Monash University 64
Testing effectiveness (Phase 2)Study completedNCT03549260
What this trial is testing

Study to Evaluate Efficacy and Safety of LIB003 in Patients on Lipid-Lowering Therapy Needing Additional LDL-C Reduction

Who this might be right for
LDL Cholesterol
LIB Therapeutics LLC 81
Next Page